Know Cancer

or
forgot password

Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography


Phase 1
18 Years
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography


Inclusion Criteria:



- Clinically Organ Confined Prostate Cancer Electing Radical Prostatectomy

Exclusion Criteria:

- Weight > 300 lb

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Histopathologic Diagnosis - sextant diagnosis by whole-prostate step section histopathologic analysis

Outcome Time Frame:

Immediate - no longitudinal data collected

Safety Issue:

No

Authority:

United States: Food and Drug Administration

Study ID:

RA-2004-040

NCT ID:

NCT01310192

Start Date:

June 2004

Completion Date:

July 2008

Related Keywords:

  • Prostate Cancer
  • Prostatic Neoplasms

Name

Location

Tripler Army Medical CenterHonolulu, Hawaii  96859-5000